81927-201-01 : NDC 2026 Code

81927-201-01 : Imatinib Oral ( Imkeldi )

Additionally :

You can get information about “81927-201-01” NDC code in 81927-201-01 in HTML format

HTML | 81927-201-01 in TXT (Plain Text) format

TXT | 81927-201-01 in PDF (Portable Document Format)

PDF | 81927-201-01 in XML format

XML formats.

NDC Code : 81927-201-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "81927-201-01",
    "PackageDescription": "140 mL in 1 BOTTLE (81927-201-01) ",
    "NDC11Code": "81927-0201-01",
    "ProductNDC": "81927-201",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Imkeldi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Imatinib Oral",
    "DosageFormName": "SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20241219",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA219097",
    "LabelerName": "Shorla Oncology Inc.,",
    "SubstanceName": "IMATINIB MESYLATE",
    "StrengthNumber": "80",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-12-20",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20241219",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}